Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 10/31/2019

Month EndAs of 10/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) 8.01 7.89 1.50 15.59 10.69
Fund with Sales Charge (%) (POP) 8.01 7.89 1.50 15.59 10.69
NASDAQ Biotechnology Index (%) 2.87 7.90 1.66 16.24 11.20
S&P 500 Index (%) 14.33 14.92 10.78 13.70 7.56
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.29 0.26 0.94 13.32 10.19
Fund with Sales Charge (%) (POP) -17.29 0.26 0.94 13.32 10.19
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

After-Tax Average Annual Total Returns [further-information] As of 10/31/2019

Month EndAs of 10/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 6.83 6.83 0.16 14.36
Fund without Sales Charge (%) (NAV) After Shares Sold 4.92 5.83 0.82 12.87
Fund with Sales Charge (%) (POP) Before Shares Sold 6.83 6.83 0.16 14.36
Fund with Sales Charge (%) (POP) After Shares Sold 4.92 5.83 0.82 12.87
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.19 -0.72 -0.39 12.11
Fund without Sales Charge (%) (NAV) After Shares Sold -10.02 0.02 0.47 10.90
Fund with Sales Charge (%) (POP) Before Shares Sold -18.19 -0.72 -0.39 12.11
Fund with Sales Charge (%) (POP) After Shares Sold -10.02 0.02 0.47 10.90

Calendar Year Returns

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund without Sales Charge (%) (NAV) -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64 11.93
Fund with Sales Charge (%) (POP) -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64 11.93
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25 15.84
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06 26.46

Cumulative Total Returns [further-information] As of 10/31/2019

Month EndAs of 10/31/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -0.38 18.45 8.01 25.60 7.75 325.77 845.62
Fund with Sales Charge (%) (POP) -0.38 18.45 8.01 25.60 7.75 325.77 845.62
NASDAQ Biotechnology Index (%) 1.42 10.71 2.87 25.61 8.60 350.45 947.53
S&P 500 Index (%) 2.43 23.16 14.33 51.73 66.81 260.96 401.02
Quarter EndAs of 09/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -14.22 6.41 -17.29 0.80 4.81 249.14 749.53
Fund with Sales Charge (%) (POP) -14.22 6.41 -17.29 0.80 4.81 249.14 749.53
NASDAQ Biotechnology Index (%) -8.76 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 1.70 20.55 4.25 45.80 67.27 246.74 390.39

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 10/31/2019 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.40 24.44 22.63
Standard Deviation (NASDAQ Biotechnology Index) 20.11 22.70 20.91
Beta 1.08 1.05 1.04
Sharpe Ratio 0.28 0.02 0.67
Information Ratio 0.00 -0.03 -0.11
Tracking Error 6.01 5.72 5.99

ADDITIONAL RISK STATISTICSAs of 10/31/2019 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.11 1.00 1.06
Beta Bear 0.93 1.01 1.02
Bull Bear Capture Ratio 1.03 1.04 0.99
% of Positive Months 52.78 56.67 61.67
Gains/Losses 1.38 1.15 1.74
Maximum Drawdown
23.49 37.55 37.55

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 10/31/2019 Updated Monthly, based on a 3-year period

Beta 1.08
Sharpe Ratio 0.28
Standard Deviation 22.40

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index